Logo

Insulet to Halt Study of Omnipod Horizon Due to Software Anomaly

Share this

Insulet to Halt Study of Omnipod Horizon Due to Software Anomaly

Shots:

  • Insulet will pause the pivotal clinical study of its wearable insulin pump Omnipod Horizon automated glucose control system due to software bug. The company anticipates the availability of updated software by the end of Apr’2020
  • The software glitch in the system may result in incorrect glucose value calculation which has the potential to impact insulin delivery. No adverse events have been reported due to this issue
  • The Omnipod insulin management system with its wearable design and disposable Pod provides up to three days of non-stop insulin delivery without the need of handling the needle with its expected availability in the market H1’21

Click here ­to­ read full press release/ article | Ref: Insulet | Image: Myomnipod


Senior Editor

This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions